Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.
Latest in Alzheimer's Disease and Dementia
Increasing severity of AD pathology inversely correlated to decreases in time from motor symptoms to dementia onset and death.
Hormone therapy may reduce risk for death from vascular dementia in older women.
Amyloid beta protein accumulation was present in the hearts of patients with Alzheimer's disease.
There is a clear lack of evidence in the pharmacologic guidance of sleep problems in dementia.
Patients with Alzheimer's disease tended to have increased thickness in the wall of their left ventricle.
The present findings, in combination with those from prior observational research, provide a solid rationale for further randomized trials.
There seems to be no effect on everyday functioning.
Eli Lilly's investigational Alzheimer's drug failed to meet the primary end point in the phase 3 EXPEDITION3 trial.
Higher levels of education and better management of cardiovascular risk factors may have contributed to this improvement.
Neurology Advisor Articles
- Migraine Relief After Chiropractic Manipulation Likely a Placebo Effect
- No Benefit for IV tPA Before Mechanical Thrombectomy in Ischemic Stroke
- Vitamin D Levels Linked to Migraine in Men
- Template Improves Quality of Report on MRI for Multiple Sclerosis
- Should EEG Periodic Discharges be Managed Similarly to Seizures?